Nearly 700,000 Americans suffer an ischemic stroke each year, and though tPA has been approved for over 25 years to treat ischemic strokes, only 5-10% of eligible patients receive this therapy due to delays in seeking medical attention. Alva Health is developing a wearable device to help older Americans living with high stroke risk monitor and detect signs of stroke. Founder and CEO Dr. Sandra Saldana shares with us her journey in applying her science and business backgrounds to create Alva Health and discusses the need for innovation for the aging population, an often neglected population.